Phase2 Labs is the nation’s first commercial molecular laboratory dedicated to the diagnostic management of acute and chronic respiratory diseases including ARDS, Chronic Obstructive Pulmonary Disease (COPD), moderate to severe asthma, interstitial lung disease, Cystic Fibrosis, and COVID-19. To manage these complex disease states, we integrate microbiologic, immunologic and genomic testing into relevant clinical pathways. We support the full spectrum of clinical diagnostics, pharmacodynamic monitoring and companion assay deployment for integrated delivery systems, accountable care organizations, payors, and pharmaceutical companies.